Abiomed Inc (ABMD)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011545
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc (ABMD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Abiomed Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Abiomed Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Abiomed Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Abiomed Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Abiomed Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Abiomed Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Magenta Medical Raises USD15 Million in Series B Financing 11
ALung Technologies Raises Funds through Series C Financing 12
Partnerships 14
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 14
Acquisition 15
Abiomed Acquires ECP from Syscore for USD13 Million 15
Abiomed Inc – Key Competitors 16
Abiomed Inc – Key Employees 17
Abiomed Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts 19
Aug 11, 2016: Abiomed Outlines Long-Term Growth Strategy and Unveils Future Products at Annual Investor Conference 20
Financial Announcements 21
Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 21
Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 22
May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 24
Jan 26, 2017: Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year 25
Jan 09, 2017: Abiomed Announces Preliminary Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year 26
Oct 27, 2016: Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year 27
Oct 27, 2016: Amedisys Previews Third Quarter 2016 Results 28
Jul 28, 2016: Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year 29
May 03, 2016: Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year 30
Feb 04, 2016: Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year 31
Jan 11, 2016: Abiomed Announces Preliminary Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year 32
Corporate Communications 33
Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 33
Feb 08, 2016: Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors 34
Government and Public Interest 35
Apr 12, 2016: Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park 35
Product News 36
Oct 19, 2017: Abiomed’s Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 36
Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology 37
Mar 19, 2017: First-Ever Presentation on Abiomed’s Impella Quality Assurance Program at the 2017 American College of Cardiology Scientific Session 38
Mar 16, 2017: Abiomed’s Impella Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations 40
Oct 25, 2016: Abiomed’s Impella Technology Showcased at TCT 2016 With More Than 25 Presentations During Scientific Sessions 42
Apr 07, 2016: Abiomed Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Abiomed Inc, Medical Equipment, Key Facts, 2017 2
Abiomed Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Abiomed Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Abiomed Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Abiomed Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Abiomed Inc, Deals By Market, 2011 to YTD 2017 9
Abiomed Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Magenta Medical Raises USD15 Million in Series B Financing 11
ALung Technologies Raises Funds through Series C Financing 12
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 14
Abiomed Acquires ECP from Syscore for USD13 Million 15
Abiomed Inc, Key Competitors 16
Abiomed Inc, Key Employees 17
Abiomed Inc, Subsidiaries 18

★海外企業調査レポート[Abiomed Inc (ABMD)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • 84 Lumber Co:戦略・SWOT・企業財務分析
    84 Lumber Co - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • MI Bioresearch Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc, is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous …
  • SBM Offshore NV (SBMO):企業の財務・戦略的SWOT分析
    SBM Offshore NV (SBMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cunard Line:企業の戦略・SWOT・財務分析
    Cunard Line - Strategy, SWOT and Corporate Finance Report Summary Cunard Line - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sinopac Financial Holdings Company Limited:企業の戦略・SWOT・財務分析
    Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Zoltek Corp:企業の戦略的SWOT分析
    Zoltek Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • PSR Group BV-製薬・医療分野:企業M&A・提携分析
    Summary PSR Group BV (PSR) is a contract research organization and staffing consultancy that operates through two divisions, namely, PSR Orphan Experts and PSR Pharma Resource. The company’s PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. It provi …
  • State Street Corporation:戦略・SWOT・企業財務分析
    State Street Corporation - Strategy, SWOT and Corporate Finance Report Summary State Street Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Renishaw Plc (RSW):企業の財務・戦略的SWOT分析
    Summary Renishaw Plc (Renishaw) is a medical device company that designs, manufactures and markets measurement, motion control, spectroscopy and precision machining products. The company offers precision measurement and process control, position and motion control, 3D laser scanning and measurement, …
  • Sanquin Blood Supply Foundation-医療機器分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • RussNeft Oil Co (RNFT):石油・ガス:M&Aディール及び事業提携情報
    Summary RussNeft Oil Company (RussNeft) is an oil and gas company that produces, refines and distributes crude oil, gas and petroleum products. The company operates through its business divisions such as geologic exploration and reserves, production, marketing, research center, transport and gas pro …
  • Dole Food Company Inc:企業のM&A・事業提携・投資動向
    Dole Food Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dole Food Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Exelon Corporation (EXC):電力:M&Aディール及び事業提携情報
    Summary Exelon Corporation (Exelon) is a utility services holding company operating across the energy value chain comprising power generation, distribution, transmission and energy sales. It generates electricity from diverse sources, including nuclear, fossil fuels and renewable energy. Exelon deli …
  • Leukocare AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • IDT Corp (IDT):企業の財務・戦略的SWOT分析
    Summary IDT Corp (IDT) is a telecommunication service provider that offers mobile application development and telecommunication services. The company provides prepaid communication and payment services and international voice termination through its retail and wholesale division. It offers services …
  • LG International Corp:企業のM&A・事業提携・投資動向
    LG International Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LG International Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Nymox Pharmaceutical Corp (NYMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆